# The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery

> **NCT06006026** · NA · UNKNOWN · sponsor: **West China Hospital** · enrollment: 9 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Ropivacaine Hydrochloride 10 MG/ML [Naropin]

## Key facts

- **NCT ID:** NCT06006026
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-28
- **Primary completion:** 2024-05-10
- **Final completion:** 2024-05-20
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06006026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06006026, "The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06006026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*